UNSPSC 51241706: Boric acid/edta/hydroxyethyl cellulose

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP400. This VA Drug Class (OP400) classifies this compound as belonging to the group CONTACT LENS SOLUTIONS.

UNSPSC 51241706 Boric acid/edta/hydroxyethyl cellulose, a Commodity code, covers pharmaceutical and over-the-counter products supplied through state and local cooperative purchasing vehicles. State and local governments procure these products—along with a broader range of generic multi-source pharmaceuticals and OTC items—via established cooperative purchasing agreements and RFPs that specify products by National Drug Code, SKU, UPC, and packaging configuration. Issuing bodies include state departments of administration, multistate cooperative purchasing alliances, and participating member agencies across multiple states. Vendors must typically comply with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain relationships with authorized wholesalers, and offer flexible pricing models such as flat price, net price formats, or WAC-minus structures. Insurance requirements are substantial, with vendors expected to carry commercial general liability coverage of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, including Oregon. Proposals were due March 26, 2026, with evaluation weighted heavily on price competitiveness (75 percent), fixed pricing for the contract term (10 percent), compliance with administrative requirements including EDI capability (5 percent each), and agreement to a 3 percent administrative fee (5 percent). Awarded vendors were to be provided to authorized wholesalers by May 15, 2026, with resulting agreements effective July 1, 2026, on a two-year contract term for new responders with optional extensions at MMCAP's discretion. Products must comply with FDA requirements and possess expiration dates of at least one year from manufacture with a minimum six-month shelf life. The RFP does not disclose specific award values or budget ranges but identifies performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials.